Clinical Trials on Attention Difficulties in Australia

Total 21 results

Otsuka Pharmaceutical Development & Commercialization...

Terminated

A Phase 1 Study to Investigate the Safety, Tolerance, Food Effect, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of Extended Release Formulations of Centanafadine (CTN) in Young Healthy Subjects

Adult Attention-deficit Hyperactivity Disorder (ADHD)

Australia
Shire

Completed

Drug Use Study With Intuniv® in Australia

Attention Deficit Hyperactivity Disorder (ADHD)

Australia
Kepler University Hospital

Completed

MinIAttention - Attention Management in Minimal Invasive Surgery

Disturbance of Attention

Austria
Lyndra Inc.

Completed

Study to Evaluate Safety/Duration in Stomach of Extended Release Capsules in Healthy Adults

Healthy | Gastric Retention

Australia
Medical University of Vienna

Completed

The Serotonin Transporter in Attention Deficit Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder

Austria
BRC Operations Pty. Ltd.

Unknown

International Study to Predict Optimised Treatment in Attention Deficit/Hyperactivity Disorder

Attention Deficit/Hyperactivity Disorder

United States, Australia, Netherlands
Eli Lilly and Company

Completed

Comparison of Slow and Fast Transition From Stimulants to Atomoxetine in Children and Adolescents With Attention Deficit/Hyperactivity Disorder(ADHD) (ADHD SWITCH)

Attention Deficit Hyperactivity Disorder

Australia, United Kingdom, Mexico
Eisai Inc.
Eisai Limited

Completed

Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer Treatment

Attention Impairment

United States, Netherlands, France, Spain, United Kingdom, Germany, Argentina, Canada, Australia, Chile
Lyndra Inc.

Completed

Study to Evaluate Safety/Duration in Stomach of Extended Release Capsules Containing Memantine Hydrochloride in Healthy Adults

Healthy | Alzheimer Disease | Gastric Retention

Australia
Eli Lilly and Company

Completed

Comparison of Atomoxetine and Placebo in Children and Adolescents With ADHD and ODD

Attention Deficit Hyperactivity Disorder | Oppositional Defiant Disorder

Australia, Belgium, Denmark, Finland, Germany, Netherlands, Spain, United Kingdom
St George Hospital, Australia

Completed

Clean Intermittant Self Catheterisation: A Trial Comparing Single Use vs Reuse of Nelaton Catheters (SURE)

Urinary Retention

Australia
Bayside Health
The Alfred

Completed

A Pilot Study of Boredom in a Community Sample of Adolescents and a Clinical Sample of Adolescents

Mental Disorders | Psychotic Disorders | Anxiety Disorders | Attention Deficit and Disruptive Behavior Disorders | Affective Disorders

Australia
Medical University of Graz
Joanneum Research Forschungsgesellschaft mbH

Completed

Lipofilling: Optimal Harvesting Techniques for Breast Reconstruction After Mastectomy in Plastic Aesthetic and Reconstructive Surgery (LipoTech)

The Impact of Adipose Tissue Quality on Fat Graft Retention

Austria
Eli Lilly and Company

Completed

Long-Term, Open Label Atomoxetine Study

Attention Deficit Hyperactivity Disorder

United States, Australia, Belgium, Canada, France, Germany, Israel, Italy, Netherlands, Norway, Puerto Rico, South Africa, Sweden, United Kingdom
Shire
Takeda Development Center Americas, Inc.

Recruiting

A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

Spain, United States, United Kingdom, Belgium, Germany, Netherlands, Portugal, Austria, Sweden
University of Vienna

Completed

Yoga Practice, Stress and Cognitive Performance

Stress | Anxiety | Inhibition | Attentional Control Switching | Task Switching Between Modalities

Austria
Medical University of Vienna

Recruiting

RCT About Two Different Regimens of Clean Intermittent Catheterization in Women With Overt Postpartum Urinary Retention (DICOPUR)

Urinary Retention | Postpartum Period

Austria
Shire

Completed

Access to Extended Release Guanfacine HCl for Subjects Who Participated in Studies SPD503-315 or SPD503-316 in Europe

Attention Deficit Hyperactivity Disorder (ADHD)

Spain, Germany, Ukraine, France, Italy, Austria, Belgium, Ireland, Netherlands, Poland, Romania, Sweden, United Kingdom
Eli Lilly and Company

Completed

A Long Term Study of a Medication for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

Spain, France, Austria, Germany, Belgium, Finland, Italy, Netherlands, Portugal, Sweden, Switzerland, United Kingdom
Shire

Completed

Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

Spain, United States, Germany, Poland, Italy, Ukraine, Romania, United Kingdom, Sweden, Austria, Canada, France, Ireland
Sanofi

Completed

Clinical Trial in Males With BPH (Enlarged Prostate)

Prostatic Hyperplasia | Urinary Retention | Benign Prostatic Hypertrophy

United States, Canada, Poland, Romania, Australia, Netherlands, Portugal, Spain, Sweden, Bulgaria, Denmark, Finland, Hungary, Norway, South Africa, Greece, Israel

Clinical Trials on Attention Difficulties in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations